Screener
IBRN vs IHE
iShares Neuroscience and Healthcare ETF vs iShares U.S. Pharmaceuticals ETF
Key differences
- IHE costs 0.09% less per year.
- IHE is significantly larger than IBRN — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, IHE has delivered higher annualized returns.
- IHE has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| IBRN | IHE | |
|---|---|---|
| Annual cost (TER) | 0.47% | 0.38% |
| Fund size (AUM) | $5M | $946M |
| Since | 2022 | 2006 |
| Dividend yield | 0.93% | 1.70% |
| Asset class | equity | equity |
| Region | — | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +56.8% | +46.2% |
| CAGR 3Y | +10.6% | +18.0% |
| CAGR 5Y | N/A | +10.1% |
| Sharpe 3Y | 0.39 | 0.87 |
| Volatility 1Y | 25.00% | 16.91% |
| Max drawdown | -35.39% | -29.59% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to IBRN and IHE
Explore further